Human immunodeficiency virus type 1 Vpr is a positive regulator of viral transcription and infectivity in primary human macrophages

被引:120
作者
Subbramanian, RA
Kessous-Elbaz, A
Lodge, R
Forget, J
Yao, XJ
Bergeron, D
Cohen, EA
机构
[1] Univ Montreal, Fac Med, Dept Microbiol & Immunol, Lab Human Retrovirol, Montreal, PQ H3C 3J7, Canada
[2] Univ Montreal, Fac Med, Dept Pathol, Montreal, PQ H3C 3J7, Canada
关键词
D O I
10.1084/jem.187.7.1103
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
It is currently well established that HIV-1 Vpr augments viral replication in primary human macrophages. In its virion-associated form, Vpr has been suggested. to aid efficient translocation of the proviral DNA into the cell nucleus. Although Vpr growth-arrests dividing T cells, the relevance of this biological activity in nondividing macrophages is unclear. Here we use Vpr-mutants to demonstrate that the molecular determinants involved in G2-arresting T cells are also involved in increasing viral transcription in macrophages, even though these cells are refractive to the diploid DNA status typical of G2 phase. Our results suggest that the two phenotypes, namely the nuclear localization and the G2-arrest activity of the protein, segregate functionally among the late and early functions of Vpr. The nuclear localization property of Vpr correlates with its ability to effectively target the proviral DNA to the cell nucleus early in the infection, whereas the G2-arrest phenotype correlates with its ability to activate viral transcription after establishment of an infection. These two functions may render Vpr's role essential and not accessory under infection conditions that closely mimic the in vivo situation, that is, primary cells being infected at low viral inputs.
引用
收藏
页码:1103 / 1111
页数:9
相关论文
共 48 条
[1]   REV IS NECESSARY FOR TRANSLATION BUT NOT CYTOPLASMIC ACCUMULATION OF HIV-1 VIF, VPR, AND ENV/VPU-2 RNAS [J].
ARRIGO, SJ ;
CHEN, ISY .
GENES & DEVELOPMENT, 1991, 5 (05) :808-819
[2]   HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B [J].
Ayyavoo, V ;
Mahboubi, A ;
Mahalingam, S ;
Ramalingam, R ;
Kudchodkar, S ;
Williams, WV ;
Green, DR ;
Weiner, DB .
NATURE MEDICINE, 1997, 3 (10) :1117-1123
[3]   DISTINCT EFFECTS IN PRIMARY MACROPHAGES AND LYMPHOCYTES OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACCESSORY GENES VPR, VPU, AND NEF - MUTATIONAL ANALYSIS OF A PRIMARY HIV-1 ISOLATE [J].
BALLIET, JW ;
KOLSON, DL ;
EIGER, G ;
KIM, FM ;
MCGANN, KA ;
SRINIVASAN, A ;
COLLMAN, R .
VIROLOGY, 1994, 200 (02) :623-631
[4]   ANTISENSE PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES TARGETED TO THE VPR GENE INHIBIT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION IN PRIMARY HUMAN MACROPHAGES [J].
BALOTTA, C ;
LUSSO, P ;
CROWLEY, R ;
GALLO, RC ;
FRANCHINI, G .
JOURNAL OF VIROLOGY, 1993, 67 (07) :4409-4414
[5]   In vitro characterization of purified human thymic dendritic cells infected with human immunodeficiency virus type 1 [J].
Beaulieu, S ;
Kessous, A ;
Landry, D ;
Montplaisir, S ;
Bergeron, D ;
Cohen, EA .
VIROLOGY, 1996, 222 (01) :214-226
[6]   NEURONAL EXPRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENV PROTEINS IN TRANSGENIC MICE - DISTRIBUTION IN THE CENTRAL-NERVOUS-SYSTEM AND PATHOLOGICAL ALTERATIONS [J].
BERRADA, F ;
MA, DM ;
MICHAUD, J ;
DOUCET, G ;
GIROUX, L ;
KESSOUSELBAZ, A .
JOURNAL OF VIROLOGY, 1995, 69 (11) :6770-6778
[7]  
COHEN EA, 1990, J ACQ IMMUN DEF SYND, V3, P11
[8]   VPR IS REQUIRED FOR EFFICIENT REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN MONONUCLEAR PHAGOCYTES [J].
CONNOR, RI ;
CHEN, BK ;
CHOE, S ;
LANDAU, NR .
VIROLOGY, 1995, 206 (02) :935-944
[9]   DETECTION OF MESSENGER-RNAS IN SEA-URCHIN EMBRYOS BY INSITU HYBRIDIZATION USING ASYMMETRIC RNA PROBES [J].
COX, KH ;
DELEON, DV ;
ANGERER, LM ;
ANGERER, RC .
DEVELOPMENTAL BIOLOGY, 1984, 101 (02) :485-502
[10]   MUTATIONAL ANALYSIS OF CELL-CYCLE ARREST, NUCLEAR-LOCALIZATION, AND VIRION PACKAGING OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VPR [J].
DIMARZIO, P ;
CHOE, S ;
EBRIGHT, M ;
KNOBLAUCH, R ;
LANDAU, NR .
JOURNAL OF VIROLOGY, 1995, 69 (12) :7909-7916